title: [Primary osseous Hodgkin's lymphoma of the sacrum: A diagnostic and therapeutic challenge].
abstract: Primary osseous Hodgkin's lymphoma is a very rare entity. Cases reported in the literature are limited with often insufficient initial exploration. We report a new case of a 24 years old patient with a diagnosis of primary osseous Hodgkin lymphoma of the lumbosacral region with extension to the soft tissues, without simultaneous lymph node involvement confirmed both by conventional and metabolic imaging. The patient received a combination chemotherapy (two courses BEACOPP®and four courses ABVD) followed by radiotherapy of the lombosacral region at the dose of 40Gy in 20 fractions. Fifteen months after the end of treatment, the patient was in complete remission.
authors.affiliation: Département de radiothérapie oncologique, CHU Farhat-Hached, Sousse Medina, 4002 Sousse, Tunisie. Electronic address: nejla_fourati@yahoo.fr.
authors.forename: N
authors.initials: N
authors.lastname: Fourati
authors.affiliation: Département de radiothérapie oncologique, CHU Farhat-Hached, Sousse Medina, 4002 Sousse, Tunisie.
authors.forename: S
authors.initials: S
authors.lastname: Kanoun Belajouza
authors.affiliation: Département d'oncohématologie, CHU Farhat-Hached, Sousse Medina, 4002 Sousse, Tunisie.
authors.forename: H
authors.initials: H
authors.lastname: Regaieg
authors.affiliation: Département d'oncohématologie, CHU Farhat-Hached, Sousse Medina, 4002 Sousse, Tunisie.
authors.forename: A
authors.initials: A
authors.lastname: Khlif
authors.affiliation: Département de radiothérapie oncologique, CHU Farhat-Hached, Sousse Medina, 4002 Sousse, Tunisie.
authors.forename: N
authors.initials: N
authors.lastname: Bouaouina
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001706:Biopsy; D001761:Bleomycin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005188:False Negative Reactions; D005260:Female; D006689:Hodgkin Disease / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D007247:Infertility, Female / Q000517:prevention & control; D017116:Low Back Pain / Q000209:etiology; D008279:Magnetic Resonance Imaging; D059351:Organ Sparing Treatments; D010019:Osteomyelitis / Q000175:diagnosis; D010053:Ovary / Q000601:surgery; D049268:Positron-Emission Tomography; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D020266:Radiotherapy, Conformal / Q000379:methods*; D012074:Remission Induction; D012447:Sacrum / Q000000981:diagnostic imaging*; D013125:Spinal Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000532:radiotherapy; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage; D055815:Young Adult
chemical_list: D001761:Bleomycin; D011344:Procarbazine; D014750:Vincristine; D014747:Vinblastine; D005047:Etoposide; D003606:Dacarbazine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
keywords: Chemotherapy; Chimiothérapie; Hodgkin's lymphoma; Lymphome de Hodgkin; Osseous; Osseux; Primary; Primitif; Radiotherapy; Radiothérapie